Have a feature idea you'd love to see implemented?
Let us know!
VTVT vTv Therapeutics Inc
Price (delayed)
$14.87
Market cap
$44.76M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$6.49
Enterprise value
-$508,237
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment
Highlights
VTVT's debt is down by 39% year-on-year and by 14% since the previous quarter
The company's EPS rose by 27% YoY and by 22% QoQ
VTVT's equity has soared by 165% year-on-year but it is down by 21% since the previous quarter
The net income has declined by 6% year-on-year but it is up by 2.1% since the previous quarter
Key stats
What are the main financial stats of VTVT
Market
Valuations
Earnings
Shares outstanding
3.01M
Market cap
$44.76M
Enterprise value
-$508,237
Price to earnings (P/E)
N/A
Price to book (P/B)
2.72
Price to sales (P/S)
44.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.51
Revenue
$1M
EBIT
-$20.07M
EBITDA
-$19.98M
Free cash flow
-$21.81M
Per share
Balance sheet
Liquidity
EPS
-$6.49
Free cash flow per share
-$7.25
Book value per share
$5.47
Revenue per share
$0.33
TBVPS
$15.43
Total assets
$46.46M
Total liabilities
$26.02M
Debt
$256,000
Equity
$16.48M
Working capital
$39.22M
Debt to equity
0.02
Current ratio
6.61
Quick ratio
6.56
Net debt/EBITDA
2.27
Margins
Efficiency
Dividend
EBITDA margin
-1,997.6%
Gross margin
100%
Net margin
-2,017.7%
Operating margin
-2,222.7%
Return on assets
-63.8%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-50.8%
Return on sales
-2,006.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VTVT stock price
How has the vTv Therapeutics stock price performed over time
Intraday
-6.77%
1 week
9.82%
1 month
12.57%
1 year
-14.54%
YTD
29.3%
QTD
9.62%
Financial performance
How have vTv Therapeutics's revenue and profit performed over time
Revenue
$1M
Gross profit
$1M
Operating income
-$22.23M
Net income
-$20.18M
Gross margin
100%
Net margin
-2,017.7%
VTVT's net margin has surged by 99% year-on-year and by 2.1% since the previous quarter
The operating margin has soared by 99% YoY and by 2.9% from the previous quarter
VTVT's operating income is up by 17% YoY and by 2.9% QoQ
The net income has declined by 6% year-on-year but it is up by 2.1% since the previous quarter
Growth
What is vTv Therapeutics's growth rate over time
Valuation
What is vTv Therapeutics stock price valuation
P/E
N/A
P/B
2.72
P/S
44.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.51
The company's EPS rose by 27% YoY and by 22% QoQ
VTVT's equity has soared by 165% year-on-year but it is down by 21% since the previous quarter
The P/S is 97% lower than the 5-year quarterly average of 1757.9
Efficiency
How efficient is vTv Therapeutics business performance
The company's return on sales has surged by 99% YoY and by 2.1% QoQ
vTv Therapeutics's return on assets has increased by 21% QoQ
Dividends
What is VTVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VTVT.
Financial health
How did vTv Therapeutics financials performed over time
VTVT's total assets is 79% greater than its total liabilities
VTVT's total assets has soared by 107% year-on-year but it is down by 14% since the previous quarter
The quick ratio has increased by 10% from the previous quarter
VTVT's debt is 98% smaller than its equity
The debt to equity has soared by 200% year-on-year and by 100% since the previous quarter
VTVT's equity has soared by 165% year-on-year but it is down by 21% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.